PBPK.org - PBPK Workshop @ The Hamner Institutes - Cancelled

Search News

Login

Syndicate

ATOM 0.3

OPML

Latest PBPK papers

Improved predictive model for n-decane kinetics across species, as a component of hydrocarbon mixtures.
Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies.
Using Dietary Exposure and Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling in Human Risk Extrapolations for Acrylamide Toxicity.
Dynamic changes in lipids and proteins of maternal, fetal and pup blood and milk during perinatal development in CD and Wistar rats.
Quantitative Interpretation of Human Biomonitoring Data.
Approaches for applications of physiologically based pharmacokinetic models in risk assessment.
Inhalation Dosimetry Modeling with Inhaled Decamethylcyclopentasiloxane in Rats and Humans.
Physiologically based pharmacokinetic model development and simulations for ethylene dichloride (1,2-dichloroethane) in rats.
Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model.
Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man.

PBPK Workshop @ The Hamner Institutes - Cancelled

PDF

Print

E-mail

Written by Martin Spendiff
Wednesday, 27 June 2007
The workshop on September 25-28, 2007 at The Hamner Institutes for Health Sciences "Physiologically Based Pharmacokinetic (PBPK) Modeling in Pharmaceutical Development" has now been cancelled.
Last Updated ( Thursday, 19 July 2007 )

< Prev		Next >

: Sitemap : © Martin Spendiff 2008